Management-related costs of Idiopathic Pulmonary Fibrosis (IPF) in Belgium
D. Strens (Leuven, Belgium), B. Bondue (Brussels, Belgium), C. Dahlqvist (Yvoir, Belgium), H. Slabbynk (Antwerpen, Belgium), J. Guiot (Liege, Belgium), G. Joos (Liege, Belgium), N. Gusbin (Liege, Belgium), W. Janssens (Brussels, Belgium), A. Froidure (Brussels, Belgium), W. Wuyts (Leuven, Belgium)
Source: Virtual Congress 2020 – How do different treatment strategies translate into costs
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Strens (Leuven, Belgium), B. Bondue (Brussels, Belgium), C. Dahlqvist (Yvoir, Belgium), H. Slabbynk (Antwerpen, Belgium), J. Guiot (Liege, Belgium), G. Joos (Liege, Belgium), N. Gusbin (Liege, Belgium), W. Janssens (Brussels, Belgium), A. Froidure (Brussels, Belgium), W. Wuyts (Leuven, Belgium). Management-related costs of Idiopathic Pulmonary Fibrosis (IPF) in Belgium. 4810
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: